TrialFrontiers in oncology2026

Academic anti CD19 CAR-T cell therapy for relapsed/refractory B-cell lymphomas in real-world clinical practice: a prospective cohort study.

Natalya E Konoplya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.